Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/124892
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells
Author: Irani, Y.D.
Hughes, A.
Clarson, J.
Kok, C.H.
Shanmuganathan, N.
White, D.L.
Yeung, D.T.
Ross, D.M.
Hughes, T.P.
Yong, A.S.M.
Citation: British Journal of Haematology, 2020; 191(3):433-441
Publisher: Wiley
Issue Date: 2020
ISSN: 0007-1048
1365-2141
Statement of
Responsibility: 
Yazad D. Irani, Amy Hughes, Jade Clarson, Chung H. Kok, Naranie Shanmuganathan, Deborah L. White, David T. Yeung, David M. Ross, Timothy P. Hughes, and Agnes S.M. Yong
Abstract: There is currently no biomarker that reliably predicts treatment-free remission (TFR) in chronic myeloid leukaemia (CML). We characterised effector and suppressor immune responses at the time of tyrosine kinase inhibitor (TKI) cessation in patients from the CML8 and CML10 clinical studies. Natural killer (NK) cells with increased expression of activating NK receptors were higher in patients who achieved TFR. There was no difference in the proportion of CD4+ or CD8+ T cells. Furthermore, we found that FoxP3+ regulatory T cells (T reg) and monocytic myeloid-derived suppressor cells (Mo-MDSCs) were concomitantly decreased in TFR patients, suggesting that the effector and suppressor arms of the immune system work in concert to mediate TFR. A discovery cohort (CML10) was used to generate a predictive model, using logistic regression. Patients classified into the high-risk group were more likely to relapse when compared with the low-risk group (HR 7·4, 95% CI 2·9-19·1). The model was successfully validated on the independent CML8 cohort (HR 8·3, 95% CI 2·2-31·3). Effective prediction of TFR success may be obtained with an effector-suppressor score, calculated using absolute NK cell, T reg, and Mo-MDSC counts, at TKI cessation, reflecting the contribution of both immune suppressors and effectors in the immunobiology underlying successful TFR.
Keywords: CML
immunobiology
treatment-free remission
Rights: © 2020 British Society for Haematology and John Wiley & Sons Ltd
DOI: 10.1111/bjh.16718
Grant ID: http://purl.org/au-research/grants/nhmrc/1059165
http://purl.org/au-research/grants/nhmrc/1138935
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.